2 terminated, 1 not yet recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Not yet recruiting 1 |
Follow Nicholas Butowski: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma. SRN-101, Blood Specimen Collection, Surgical Resection - Recurrent High-Grade Gliomas, Brain Neoplasm | Phase 1 | Not yet recruiting | Nicholas Butowski | 6 | 2026-11-15 | 2026-10-27 |
| RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma RMC-5552 - Glioblastoma, Recurrent Glioblastoma | Phase 1 | Terminated | Nicholas Butowski | 7 | 2023-04-03 | 2026-05-06 |
| A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) IMA950, poly-ICLC, Varlilumab - Glioma, Malignant Glioma | Phase 1 | Terminated | Nicholas Butowski | 14 | 2017-04-03 | 2024-06-14 |
Glioma (2) · Astrocytoma (1) · Brain Neoplasms (1) · Glioblastoma (1) · Lymphoma, Follicular (1) · Oligodendroglioma (1)
Blood Specimen Collection (1) · EIF4EBP1 protein, human (1) · IMA950 (1) · Magnetic Resonance Spectroscopy (1) · Mechanistic Target of Rapamycin Complex 1 (1) · poly ICLC (1) · varlilumab (1)
United States (3)
P50CA097257 (1), R21CA233856 (1)